Clene Inc (CLNN)

May 03, 2025

Geode Capital Management LLC Grows Stake in Clene Inc. (NASDAQ:CLNN) - Defense World

May 03, 2025

Apr 29, 2025

Clene Inc. Enters Agreement for $25M Equity Distribution By Investing.com - Investing.com Nigeria

Apr 29, 2025

Apr 28, 2025

Clene Inc. Enters Agreement for $25M Equity Distribution - Investing.com Australia

Apr 28, 2025

Apr 28, 2025

Clene Inc.Enters Equity Distribution Agreement With CanaccordSEC Filing - marketscreener.com

Apr 28, 2025

Apr 26, 2025

Analysts Set Clene Inc. (NASDAQ:CLNN) Target Price at $55.25 - Defense World

Apr 26, 2025

Apr 26, 2025

Clene (NASDAQ:CLNN) Research Coverage Started at Jones Trading - Defense World

Apr 26, 2025

Apr 23, 2025

Clene (CLNN) Receives Buy Rating and $30 Target from JonesResear - GuruFocus

Apr 23, 2025

Apr 23, 2025

Clene (CLNN) Receives Buy Rating and $30 Target from JonesResearch | CLNN Stock News - GuruFocus

Apr 23, 2025

Apr 14, 2025

Clene to Present at the Emerging Growth Conference | CLNN Stock News - GuruFocus

Apr 14, 2025

Apr 14, 2025

Nanomedicines Market to Witness Massive Growth by 2032 | Abbott - openPR.com

Apr 14, 2025

Apr 14, 2025

Clene to Present at the Emerging Growth Conference - The Manila Times

Apr 14, 2025

Apr 11, 2025

Clene’s (CLNN) “Buy” Rating Reiterated at D. Boral Capital - Defense World

Apr 11, 2025

Apr 11, 2025

Nanomedicines Market Generated Opportunities, Future Scope 2025-2032 | Abbott, CombiMatrix, Clene Nanomedicine - newstrail.com

Apr 11, 2025

Apr 11, 2025

Clene’s (CLNN) Buy Rating Reiterated at HC Wainwright - Defense World

Apr 11, 2025

Apr 08, 2025

Clene reports MS patient improvements with CNM-Au8 treatment By Investing.com - Investing.com India

Apr 08, 2025

Apr 08, 2025

Clene announces evidence of remyelination, neuronal repair with CNM-Au8 - TipRanks

Apr 08, 2025

Apr 08, 2025

Clene reports MS patient improvements with CNM-Au8 treatment - Investing.com Australia

Apr 08, 2025

Apr 08, 2025

Breakthrough: New MS Drug Actually Repairs Brain Damage, Trial Data Shows 90% Success Rate - Stock Titan

Apr 08, 2025

Apr 01, 2025

Clene (NASDAQ: CLNN) to Present at Jones Healthcare and Technology Innovation Conference - The Globe and Mail

Apr 01, 2025

Apr 01, 2025

CLNN stock touches 52-week low at $2.95 amid market challenges By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

CLNN stock touches 52-week low at $2.95 amid market challenges - Investing.com India

Apr 01, 2025

Apr 01, 2025

Clene to Present at the Jones Healthcare and Technology Innovation Conference - The Manila Times

Apr 01, 2025

Apr 01, 2025

Clene Reveals Latest ALS and MS Treatment Innovations at Major Healthcare Conference - Stock Titan

Apr 01, 2025

Mar 30, 2025

Promising Nanotechnology Stocks To ResearchMarch 29th - MarketBeat

Mar 30, 2025

Mar 28, 2025

Roth Capital Has Negative Estimate for Clene Q1 Earnings - Defense World

Mar 28, 2025

Mar 27, 2025

Clene Inc. settles debt with equity issuance - Investing.com

Mar 27, 2025

Mar 27, 2025

Clene Inc.'S (NASDAQ: CLNN) Q1 Virtual Investor Summit Presentation Available For On-Demand Viewing - MENAFN.COM

Mar 27, 2025

Mar 27, 2025

Roth Capital Has Optimistic Outlook of Clene FY2027 Earnings - Defense World

Mar 27, 2025

Mar 27, 2025

Research Analysts Issue Forecasts for Clene Q1 Earnings - Defense World

Mar 27, 2025

Mar 26, 2025

Clene (NASDAQ:CLNN) Earns Buy Rating from D. Boral Capital - The AM Reporter

Mar 26, 2025

Mar 26, 2025

What is HC Wainwright’s Estimate for Clene FY2028 Earnings? - Defense World

Mar 26, 2025

Mar 25, 2025

Clene stock touches 52-week low at $3.8 amid market challenges - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

Clene stock touches 52-week low at $3.8 amid market challenges By Investing.com - Investing.com South Africa

Mar 25, 2025

Mar 25, 2025

H.C. Wainwright maintains $31 target on Clene stock post-results By Investing.com - Investing.com Canada

Mar 25, 2025

Mar 25, 2025

Clene to Participate in Jones Las Vegas Technology and Innovation Conference on April 8-9, 2025 - StreetInsider.com

Mar 25, 2025

Mar 25, 2025

H.C. Wainwright maintains $31 target on Clene stock post-results - Investing.com

Mar 25, 2025

Mar 25, 2025

Clene (NASDAQ:CLNN) Given “Buy” Rating at HC Wainwright - Defense World

Mar 25, 2025

Mar 25, 2025

Clene’s (CLNN) Buy Rating Reaffirmed at D. Boral Capital - Defense World

Mar 25, 2025

Mar 25, 2025

Clene Inc. Reports 2024 Financial Results and Strategic Plans - TipRanks

Mar 25, 2025

Mar 24, 2025

Clene Inc (CLNN) Reports Q4 EPS of -$5.67, Revenue of $0.36M, Mi - GuruFocus

Mar 24, 2025

Mar 24, 2025

Clene Inc. Files For Mixed Shelf Of Up To $160 MillionSEC Filing -March 24, 2025 at 04:51 pm EDT - MarketScreener

Mar 24, 2025

Mar 24, 2025

Clene (NASDAQ: CLNN) Plans 2025 NDA Submission Following Positive ALS Trial Data - Barchart.com

Mar 24, 2025

Mar 24, 2025

Clene Inc. reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 24, 2025

Mar 24, 2025

Clene Inc. (CLNN) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 24, 2025

Mar 24, 2025

Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights - The Manila Times

Mar 24, 2025

Mar 24, 2025

Breakthrough: Clene's ALS Treatment Shows 11.9-Month Survival Benefit in Severe Cases - Stock Titan

Mar 24, 2025

Mar 21, 2025

BiomednewsbreaksClene Inc. (NASDAQ: CLNN) Unveils Progress On CNM-Au8(R), Eyes Potential Fast-Track FDA Approval - MENAFN.COM

Mar 21, 2025

Mar 20, 2025

Bullish Clene Insiders Loaded Up On US$583.4k Of Stock - Yahoo

Mar 20, 2025